PULM · Company research
Pulmatrix, Inc. Common Stock (PULM): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
15records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Pulmatrix Stock Price Forecast. Should You Buy PULM? - StockInvest.us | Pulmatrix Stock Price Forecast. Should You Buy PULM? StockInvest.us | View source ↗ | StockInvest.us | Oct 16, 2026 | neutral | 0 | 0.6 |
| Semaglutide-treated aged mice lost late-life lean mass. Pulmatrix (PULM) shares a PTC-2105 comparison. - Stock Titan | Semaglutide-treated aged mice lost late-life lean mass. Pulmatrix (PULM) shares a PTC-2105 comparison. Stock Titan | View source ↗ | Stock Titan | Oct 13, 2026 | neutral | 0 | 0.6 |
| Pulmatrix (PULM) Slips 4.39% to $1.46, Drifting Toward Lower Support - Arms Index - https://www.dars.gov.et/ | Pulmatrix (PULM) Slips 4.39% to $1.46, Drifting Toward Lower Support - Arms Index https://www.dars.gov.et/ | View source ↗ | https://www.dars.gov.et/ | Oct 11, 2026 | neutral | 0 | 0.6 |
| No resale proceeds will go to Pulmatrix (PULM) under its amended share registration. - Stock Titan | No resale proceeds will go to Pulmatrix (PULM) under its amended share registration. Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| Pulmatrix, Inc. SEC Filing (Oct 5, 2026) - Stock Titan | Pulmatrix, Inc. SEC Filing (Oct 5, 2026) Stock Titan | View source ↗ | Stock Titan | Oct 5, 2026 | neutral | 0 | 0.6 |
| PULM Forecast — Price Target — Prediction for 2027 - TradingView | PULM Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Oct 3, 2026 | neutral | 0 | 0.6 |
| One exhibit removed: Pulmatrix (PULM) amends its business combination paperwork. - Stock Titan | One exhibit removed: Pulmatrix (PULM) amends its business combination paperwork. Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| New MTXL ticker planned if Pulmatrix (NASDAQ: PULM) investors approve Eos merger - Stock Titan | New MTXL ticker planned if Pulmatrix (NASDAQ: PULM) investors approve Eos merger Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| Pulmatrix (PULM) Holds Steady at $1.47 as Shares Trade Between Key Support and Resistance Levels - Overbought Signal Alerts - siam.in | Pulmatrix (PULM) Holds Steady at $1.47 as Shares Trade Between Key Support and Resistance Levels - Overbought Signal Alerts siam.in | View source ↗ | siam.in | Sep 1, 2026 | neutral | 0 | 0.6 |
| Pulmatrix (PULM) Gains 1.99% to $1.54 as Stock Holds Above Key Support - Growth ETF - www.dars.gov.et | Pulmatrix (PULM) Gains 1.99% to $1.54 as Stock Holds Above Key Support - Growth ETF www.dars.gov.et | View source ↗ | www.dars.gov.et | Aug 15, 2026 | neutral | 0 | 0.6 |
| Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger - PR Newswire | Pulmatrix Announces Closing of Preferred Stock Transaction as Part of Planned Merger PR Newswire | View source ↗ | PR Newswire | Apr 21, 2026 | neutral | 0 | 0.6 |
| PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders - Business Wire | PULM Stock Alert: Halper Sadeh LLC is Investigating Whether Pulmatrix, Inc. is Obtaining a Fair Price for its Shareholders Business Wire | View source ↗ | Business Wire | Apr 13, 2026 | neutral | 0 | 0.6 |
| Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead - Stocktwits | Pulmatrix Shares Dive As Privately-Held Pharma Company Chooses To Merge With Gyre Therapeutics Instead Stocktwits | View source ↗ | Stocktwits | Mar 2, 2026 | neutral | 0 | 0.6 |
| Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets - PR Newswire | Pulmatrix Announces Third Quarter 2025 Financial Results and Divestment Plan for Migraine and Inhalation Assets PR Newswire | View source ↗ | PR Newswire | Oct 16, 2025 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Apr 8, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.